MALAT1 and posterior cortical atrophy: Furthermore, we showed that a circulating MALAT-1 fragment (MD-miniRNA) outperformed PSA in predicting prostate biopsy outcomes, suggesting that MALAT-1 may be a promising biomarker for diagnosing PCa.